Administration of the broadly neutralizing, CD4-binding site targeting antibody VRC07-523LS in dual- and triple-antibody combinations with 10-1074, PGT121, and/or PGDM1400: Impact on pharmacokinetics compared to VRC07-523LS administration alone
Publication
, Conference
Walsh, S; Gay, C; Sobieszczyk, M; Mannheimer, S; Hyrien, O; Yu, C; Seaton, K; Skalland, T; Dumond, J; Andrew, P; Karg, C; Paez, C; Gamble, T ...
Published in: JOURNAL OF THE INTERNATIONAL AIDS SOCIETY
2022
Duke Scholars
Published In
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY
EISSN
1758-2652
Publication Date
2022
Volume
25
Start / End Page
113 / 114
Related Subject Headings
- 4206 Public health
- 4202 Epidemiology
- 3202 Clinical sciences
- 1199 Other Medical and Health Sciences
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Walsh, S., Gay, C., Sobieszczyk, M., Mannheimer, S., Hyrien, O., Yu, C., … Karuna, S. (2022). Administration of the broadly neutralizing, CD4-binding site targeting antibody VRC07-523LS in dual- and triple-antibody combinations with 10-1074, PGT121, and/or PGDM1400: Impact on pharmacokinetics compared to VRC07-523LS administration alone. In JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (Vol. 25, pp. 113–114).
Walsh, S., C. Gay, M. Sobieszczyk, S. Mannheimer, O. Hyrien, C. Yu, K. Seaton, et al. “Administration of the broadly neutralizing, CD4-binding site targeting antibody VRC07-523LS in dual- and triple-antibody combinations with 10-1074, PGT121, and/or PGDM1400: Impact on pharmacokinetics compared to VRC07-523LS administration alone.” In JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 25:113–14, 2022.
Walsh S, Gay C, Sobieszczyk M, Mannheimer S, Hyrien O, Yu C, et al. Administration of the broadly neutralizing, CD4-binding site targeting antibody VRC07-523LS in dual- and triple-antibody combinations with 10-1074, PGT121, and/or PGDM1400: Impact on pharmacokinetics compared to VRC07-523LS administration alone. In: JOURNAL OF THE INTERNATIONAL AIDS SOCIETY. 2022. p. 113–4.
Walsh, S., et al. “Administration of the broadly neutralizing, CD4-binding site targeting antibody VRC07-523LS in dual- and triple-antibody combinations with 10-1074, PGT121, and/or PGDM1400: Impact on pharmacokinetics compared to VRC07-523LS administration alone.” JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, vol. 25, 2022, pp. 113–14.
Walsh S, Gay C, Sobieszczyk M, Mannheimer S, Hyrien O, Yu C, Seaton K, Skalland T, Dumond J, Andrew P, Karg C, Paez C, Gamble T, He Z, Hanscom B, Dye B, Piwowar-Manning E, Hural J, Polakowski L, Yacovone M, Chege W, Montefiori D, Gama L, Mascola J, Tomaras G, Huang Y, Karuna S. Administration of the broadly neutralizing, CD4-binding site targeting antibody VRC07-523LS in dual- and triple-antibody combinations with 10-1074, PGT121, and/or PGDM1400: Impact on pharmacokinetics compared to VRC07-523LS administration alone. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY. 2022. p. 113–114.
Published In
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY
EISSN
1758-2652
Publication Date
2022
Volume
25
Start / End Page
113 / 114
Related Subject Headings
- 4206 Public health
- 4202 Epidemiology
- 3202 Clinical sciences
- 1199 Other Medical and Health Sciences
- 1117 Public Health and Health Services
- 1103 Clinical Sciences